A correlation analysis of miRNA‑34a and its predicted target genes in leukemia

Tang,Ruihong; Li,Juanjuan; Yue,Mei; Liu,Ziqin; Feng,Shunqiao; Tang,Suoqin; Wang,Tianyou

doi:10.3892/mmr.2014.1931

A correlation analysis of miRNA‑34a and its predicted target genes in leukemia

Authors:
- Ruihong Tang
- Juanjuan Li
- Mei Yue
- Ziqin Liu
- Shunqiao Feng
- Suoqin Tang
- Tianyou Wang
View Affiliations

Affiliations: Department of Hematology, Capital Institute of Pediatrics‑Affiliated Children's Hospital, Beijing 100020, P.R. China, Department of Pediatrics, PLA General Hospital, Beijing 100853, P.R. China
Published online on: February 3, 2014 https://doi.org/10.3892/mmr.2014.1931
Pages: 1283-1288

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

microRNA‑34a (miRNA‑34a) plays an important role in the pathogenesis of leukemia. This study aimed to explore its role in the proliferation of HL‑60 cells and the correlation with some of its predicted target genes: the cyclin‑dependent kinase 4 (CDK4), the oncogene MYB and the silent information regulator 1 (SIRT1). We first analyzed the expression of miR‑34a, CDK4, MYB and SIRT1 in peripheral blood samples from acute leukemia (AL) patients and healthy controls, and conducted a correlation analysis. HL‑60 cells were then transfected with miR‑34a and control ʻscramble̓ miRNA, and quantitative RT‑PCR and western blotting were used to analyze the effects of the interfering sequence in HL‑60 cells. The expression of miR‑34a was significantly reduced in AL patients compared to healthy controls (P<0.01), and negatively correlated with the expression of CDK4 and MYB. Sub‑group analysis revealed that the expression of MYB was significantly lower in AL children <3 years old compared to those >3 years. Following the transfection of HL‑60 cells with miR‑34a, the mRNA level of CDK4, MYB and SIRT1 decreased by 53.2, 43.3 and 33.5%, respectively, compared to the control, similarly to the respective changes in protein levels. This study showed that the expression of miR‑34a negatively correlates with the expression of CDK4 and MYB in pediatric patients with acute leukemia. miRNA‑34a downregulates the expression of the CDK4, MYB and SIRT1 genes in vitro; it may thus represent a novel therapeutic target for acute leukemia.

View Figures

View References

1	Yamakuchi M and Lowenstein CJ: MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle. 8:712–715. 2009. View Article : Google Scholar : PubMed/NCBI
2	Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA and Cohen MB: MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther. 7:1288–1296. 2008. View Article : Google Scholar : PubMed/NCBI
3	Paris R, Henry RE, Stephens SJ, McBryde M and Espinosa JM: Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation. Cell Cycle. 7:2427–2433. 2008. View Article : Google Scholar : PubMed/NCBI
4	Mert U, Ozgür E, Tiryakioglu D, Dalay N and Gezer U: Induction of p53-inducible microRNA miR-34 by gamma radiation and bleomycin are different. Front Genet. 3:2202012. View Article : Google Scholar : PubMed/NCBI
5	Yamakuchi M, Ferlito M and Lowenstein CJ: miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
6	Tazawa H, Tsuchiya N, Izumiya M and Nakagama H: Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007. View Article : Google Scholar : PubMed/NCBI
7	He X, He L and Hannon GJ: The guardian’s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67:11099–11101. 2007.
8	Tarasov V, Jung P, Verdoodt B, et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
9	Kumamoto K, Spillare EA, Fujita K, et al: Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res. 68:3193–3203. 2008. View Article : Google Scholar : PubMed/NCBI
10	He L, He X, Lim LP, et al: A microRNA component of the p53 tumour suppressor network. Nature. 447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
11	Navarro F, Gutman D, Meire E, et al: miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood. 114:2181–2192. 2009. View Article : Google Scholar : PubMed/NCBI
12	Li L, Wu J, Sima X, et al: Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol. 34:1919–1923. 2013. View Article : Google Scholar : PubMed/NCBI
13	Ji Q, Hao X, Meng Y, et al: Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 8:2662008. View Article : Google Scholar : PubMed/NCBI
14	Ji Q, Hao X, Zhang M, et al: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 4:e68162009. View Article : Google Scholar : PubMed/NCBI
15	Pang Y, Young CY and Yuan H: MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai). 42:363–369. 2010. View Article : Google Scholar : PubMed/NCBI
16	Dalgard CL, Gonzalez M, deNiro JE and O’Brien JM: Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest Ophthalmol Vis Sci. 50:4542–4551. 2009. View Article : Google Scholar : PubMed/NCBI
17	Zenz T, Mohr J, Eldering E, et al: miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood. 113:3801–3808. 2009. View Article : Google Scholar : PubMed/NCBI
18	Wang J, Liu L, Xie L, Xiang G and Zhou Y: Induction of differentiation-specific miRNAs in TPA-induced myeloid leukemia cells through MEK/ERK activation. Int J Mol Med. 31:59–66. 2013.PubMed/NCBI
19	Vissers MC, Jester SA and Fantone JC: Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol Methods. 110:203–207. 1988. View Article : Google Scholar : PubMed/NCBI
20	Rücker FG, Russ AC, Cocciardi S, et al: Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia. 27:353–361. 2013.PubMed/NCBI
21	Visone R and Croce CM: MiRNAs and cancer. Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar
22	Kelly L, Bryan K, Kim SY, et al: Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]. PLoS One. 8:e641022013.PubMed/NCBI
23	Tuccoli A, Poliseno L and Rainaldi G: miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle. 5:2473–2476. 2006. View Article : Google Scholar : PubMed/NCBI
24	Isken F, Steffen B, Merk S, et al: Identification of acute myeloid leukaemia associated microRNA expression patterns. Br J Haematol. 140:153–161. 2008. View Article : Google Scholar : PubMed/NCBI
25	Garzon R, Heaphy CE, Havelange V, et al: MicroRNA 29b functions in acute myeloid leukemia. Blood. 114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
26	Sun F, Fu H, Liu Q, et al: Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582:1564–1568. 2008. View Article : Google Scholar : PubMed/NCBI
27	Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM and Stallings RL: MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC Cancer. 11:332011. View Article : Google Scholar : PubMed/NCBI
28	Pilotti S, Della Torre G, Mezzelani A, et al: The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer. 82:1271–1275. 2000.PubMed/NCBI
29	Dong Y, Sui L, Sugimoto K, Tai Y and Tokuda M: Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer. 95:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
30	Weber BL, Westin EH and Clarke MF: Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-MYB mRNA. Science. 249:1291–1293. 1990. View Article : Google Scholar : PubMed/NCBI